Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201
Diabetes Care
.
2017 Feb;40(2):e23-e24.
doi: 10.2337/dci16-0036.
Authors
William T Cefalu
1
,
John B Buse
2
,
Jaakko Tuomilehto
3
4
5
6
,
G Alexander Fleming
7
,
Ele Ferrannini
8
,
Hertzel C Gerstein
9
,
Peter H Bennett
10
,
Ambady Ramachandran
11
,
Itamar Raz
12
,
Julio Rosenstock
13
,
Steven E Kahn
14
Affiliations
1
Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA william.cefalu@pbrc.edu.
2
University of North Carolina School of Medicine, Chapel Hill, NC.
3
Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
4
Dasman Diabetes Institute, Dasman, Kuwait.
5
Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.
6
Center for Vascular Prevention, Danube University Krems, Krems, Austria.
7
Kinexum, Harper's Ferry, WV.
8
CNR Institute of Clinical Physiology, Pisa, Italy.
9
McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
10
National Institutes of Health, Phoenix, AZ.
11
India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
12
Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.
13
Dallas Diabetes Research Center at Medical City and The University of Texas Southwestern Medical Center, Dallas, TX.
14
VA Puget Sound Health Care System and University of Washington, Seattle, WA.
PMID:
28108540
PMCID:
PMC5864140
DOI:
10.2337/dci16-0036
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Diabetes Mellitus, Type 2*
Humans
Hyperglycemia*
Grants and funding
P50 AT002776/AT/NCCIH NIH HHS/United States
U54 GM104940/GM/NIGMS NIH HHS/United States